Vaso-occlusive Crisis clinical trials at UCSF
1 in progress, 0 open to eligible people
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Sorry, in progress, not accepting new patients
This is an open label extension study in subjects with Sickle Cell Disease (SCD) who have completed the double blind Phase 3 study (B5201002).
Oakland, California and other locations